FindTrial
Sign In

Homoeopathic Medicine for Hypertension in Postmenopausal Women

Effect of GLONOINE in 50-millesimal potency on decreased Oestradiol linked Vasomotor Symptoms with Hypertension in Postmenopausal Women: An Open-Label, Prospective, Single arm, Clinical Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092609
Enrollment
48
Registered
2025-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N958- Other specified menopausal and perimenopausal disorders

Interventions

Intervention1: Homoeopathic medicine Glonoine in 50- millesimal potency on decreased estradiol linked vasomotor symptoms with hypertension in postmenopausal women.: Patients will be given homoeopathic

Sponsors

The Calcutta Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age: 45-55 years. 2 . Confirmed diagnosis of primary hypertension. (BP greater than 140/90 mmHg). 3. Serum estradiol less than 20pg/ml. 4. Participants who will cover the characteristics symptoms of Glonoine (Nitro-glycerin). 5. Providing written informed consent to take part in the study

Exclusion criteria

Exclusion criteria: 1. The cases of Malignant Hypertension. (rise in BP more than 180/120mmHg). 2. Participants who will not covers the characteristics symptoms of Glonoine (Nitro-glycerin).3 Secondary hypertension (hypertension due to an underlying condition, such as kidney disease, any kind of cardiovascular events (e.g., myocardial infarction, stroke) within the past 6 months.4. Use of hormone replacement therapy (HRT) within the past 6 weeks. 5. Known allergy or adverse reaction to homeopathic treatments, specifically Glonoine.6. Diagnosed case of unstable mental or physical illness or other uncontrolled systemic illness or life - threatening.7. Infections (e.g., malignancy) affecting quality of life or any vital organ failure.8. Patient taking any homoeopathic medicine or medicine taken from others therapeutic system for her illness since last 6 weeks.

Design outcomes

Primary

MeasureTime frame
1.Measurement of serum estradiol level 2. Measurement of forearm blood pressure 3. Measuring Menopausal Rating score.Timepoint: At baseline, and every month, up to 3 months.—

Secondary

MeasureTime frame
Secondary outcome: 1.Measuring the MENQOL score before treatment. It consists 29 questions and score range 0 to 6 (not at all bothered to extremely bothered).Timepoint: At baseline, and every month, up to 3 months.—

Countries

India

Contacts

Public ContactKisor Kumar Naskar

The Calcutta Homoeopathic Medical College and Hospital

drkisorkumarnaskar@gmail.com9123331475

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026